Chemokines in seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 1 I, 1996, Pages 104-112

  Kuna, Piotr ^a   Lazarovich, Mark ^a   Kaplan, Allen P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

chemokines; histamine releasing factor; IL 8; Monocyte chemotactic protein 1; RANTES; rhinitis

Indexed keywords

CYTOKINE; HISTAMINE; INTERLEUKIN 8; TRYPTASE;

ADULT; ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; PRIORITY JOURNAL; RAGWEED; SEASONAL VARIATION; STATISTICAL ANALYSIS; TISSUE CULTURE;

EID: 0030042430     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70288-9     Document Type: Article

References (42)

1. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 1992;175:489-93.
2. Alam R, Lett-Brown MA, Forsythe PA, et al. Monocyte chemotactic and activating factor is a potent histamine releasing factor for basophils. J Clin Invest 1992;89:723-8.
3. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992;149:636-42.
4. Bischoff SC, Krieger M, Brunner T, et al. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993;23:761-7.
5. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 1992;176:781-6.
6. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993;150:1932-43.
7. Dahinden CA, Kurimoto Y, De Weck AL, Lindley I, Dewald B, Baggiolini M. The neutrophil-activating peptide NAF/NAP-1 induces histamine release and leukotriene release by interieukin 3-primed basophils. J Exp Med 1989;170:1787-92.
8. Reddigari SR, Kuna P, Miragliotta GF, et al. Connective tissue-activating peptide-III and its derivative, neutrophil activating peptide-2, release histamine from human basophils. J ALLERGY CLIN IMMUNOL 1992;89:666-72.
9. Kuna P, Reddigari SR, Kornfeld D, Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 1991;147:1920-4.
10. Alam R, Forsythe PA, Lett-Brown MA, Grant JA. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor. Am J Respir Cell Mol Biol 1992;7:427-33.
11. Leonard ED, Skeel A, Yoshimura T. Biological aspects of monocyte chemoattractant protein-1 (MCP-1). In: Westwick J, Kunkel SL, Lindiey I, eds. Chemotactic cytokines: biology of the inflammatory peptide supergene family. New York: Plenum, 1991:57-61.
12. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosiniphils. J Exp Med 1992;176:587-92.
13. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil Influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J ALLERGY CLIN IMMUNOL 1988;81:580-9.
14. Juliusson S, Pipkorn U, Karlsson G, Enerback L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J ALLERGY CLIN IMMUNOL 1992;90:898-909.
15. Sim TC, Alam R, Forsythe PA, Welter JB, Lett-Brown MA, Grant JA. Measurements of histamine releasing factor activity in individual nasal washings: relationship with atopy, basophil response, and membrane-bound IgE. J ALLERGY CLIN IMMUNOL 1992;89:1157-65.
16. Sim TC, Hilsmeier KA, Alam R, Allen RK, Lett-Brown MA, Grant JA. Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. A double-blind, randomized, placebo-controlled study. Am Rev Respir Dis 1992;145:1316-20.
17. Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy. J ALLERGY GLIN IMMUNOL 1992;89:87-94.
18. Beaven MA, Jacobsen A, Horakova Z. Modification of an enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum, and urine. Clin Chem Acta 1972;37:91-103.
19. Wenzell SE, Fowler AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988;137:1002-6.
20. Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
21. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
22. Alam R, Stafford S, Forsythe O, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-7.
23. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-71.
24. Schall TJ, Bacon K, Camp RDD, Kaspari J, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1α) and MIP-1β chemokines attract distinct population of lymphocyte. J Exp Med 1993;177:1763-74.
25. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-83.
26. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 1993;260:355-8.
27. Alam R, Forsythe P, Stafford S, et al. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibro-blast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol 1994;153:3155-9.
28. Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;176:751-6.
29. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
30. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313:65-70.
31. Linder A, Strandberg K, Deuschl H. Variations in histamine concentrations in nasal secretion in patients with allergic rhinitis. Allergy 1988;43:119-26.
32. Linder A, Venge P, Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 1988;42:583-90.
33. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994;149:339-44.
34. Kaplan AP, Kuna P, Reddigari SR. Chemokines as allergic mediators: relationship to histamine-releasing factors. Allergy 1994;49:495-501.
35. Naclerio RM. The role of histamine in allergic rhinitis. J ALLERGY CLIN IMMUNOL 1990;86:628-32.
36. Rathanaswami P, Hachicha M, Sadick M. Schall TJ, Me-Coll SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993;268:5834-9.
37. Kuna P, Reddigari SR, Rucinski D, Schall TJ, Kaplan AP. Chemokines of the α-β-sublass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J ALLERGY CLIN IMMUNOL 1995;95:574-86.
38. Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993;151:7216-23.
39. Kimmit P, Humbert M, Durham SR, Kay AB, Corrigan CJ. Elevated expression of IL-5 mRNA in the bronchial mucosa is a reflection of asthmatic, but not atopic status [Abstract]. J ALLERGY CLIN IMMUNOL 1995;95:222.
40. Bisgaard H, Grenburg H, Mygind N, Dahl R, Lindgvist N, Venge P. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J ALLERGY CLIN IMMUNOL 1990;85:891-5.
41. Talbot SF, Atkins PC, Valenzano M, Zweiman B. Correlations of in vivo mediator release with late cutaneous allergic responses in humans. I. Kinetics of histamine release. J ALLERGY CLIN IMMUNOL 1984;74:819-26.
42. Reshef A, Kagey-Sobotka A, Adkinson NF Jr, Lichtenstein LM, Norman PS. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). J ALLERGY CLIN IMMUNOL 1989;84:678-87.